Our further analysis found that for tumor patients with higher PSAT1 expression, such as ACC, KIRC, KIRP, LIHC, sarcoma (SARC) and UVM, the overexpression of PSAT1 is associated with poor OS. Here, PSAT1 is linked to neoplasm.